Harold Fleming

Harold Fleming

Director/Board Member at CRISPR THERAPEUTICS AG

Net worth: - $ as of 31/05/2026

62 year
Health Technology
Consumer Services
Technology Services

Profile

Harold Edward Fleming is currently Independent Director at CRISPR Therapeutics AG since 2021, Director at Komodo Health, Inc. since 2021, Director-Visitors Board at Vanderbilt School of Medicine Basic Sciences, Independent Director at Upstream Bio, Inc. since 2023, Independent Non-Executive Director at Sionna Therapeutics, Inc. since 2024, Director at Sudo Biosciences, Inc., Director at Egnite, Inc., and Executive Vice President at Enavate Sciences since 2022.
Formerly, Senior Partner at Mckinsey & Co., Inc. (California) from 1997 to 2022.
Education includes undergraduate degree from Harvard University and doctorate from Vanderbilt University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
09/06/2026 0 ( -.--% ) - $ 31/05/2026
05/06/2026 0 ( -.--% ) - $ 31/05/2026
17/06/2026 0 ( -.--% ) - $ 31/05/2026

Harold Fleming active positions

CompaniesPositionStart
CRISPR THERAPEUTICS AG Director/Board Member 10/06/2021
UPSTREAM BIO, INC. Director/Board Member 08/06/2023
SIONNA THERAPEUTICS, INC. Director/Board Member 01/03/2024
Director/Board Member 30/11/2021
Director/Board Member -
Corporate Officer/Principal 01/11/2022
Director/Board Member -
Director/Board Member -

Former positions of Harold Fleming

CompaniesPositionEnd
Corporate Officer/Principal 01/08/2022
See the detail of Harold Fleming's experience

Training of Harold Fleming

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

12

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Consumer Services

Consumer Services

Health Technology

Technology Services

Commercial Services

Health Technology

Health Technology

Technology Services

Consumer Services

Finance

Health Technology

  1. Stock Market
  2. Insiders
  3. Harold Fleming